COX-2 can be released by cancer-associated fibroblasts, M2 macrophages and cancer cells to the tumor microenvironment, inducing cancer stem cell-like activity and cell proliferation, angiogenesis, invasion, inflammation, metastasis and apoptotic resistance [39]. The gene discussed is PTGS2; the disease is neoplasm.